Fluphenazine Hydrochloride Tablet, Film Coated
Product Images NDC 51672-4233

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fluphenazine Hydrochloride (NDC 51672-4233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Fluphenazine 01)

FDA Label Image

Principal Display Panel (1 mg Tablet Bottle Label)

Principal Display Panel (1 mg Tablet Bottle Label)
This text appears to be a medication label and contains information on the dosage, composition, and manufacturer of Fluphenazine Hydrochloride tablets. The recommended dosage is not clear but it is suggested to be taken after consulting with a pharmacist or doctor. The medicine contains certain ingredients and should be stored carefully when not in use. There is also information on the manufacturer's address and contact details. Overall, the text provides some basic details on the usage of Fluphenazine Hydrochloride tablets.*
FDA Label Image

Principal Display Panel (2.5 mg Tablet Bottle Label)

Principal Display Panel (2.5 mg Tablet Bottle Label)
This is a description for a medication. The medication is called Fluphenazine and it comes in the form of tablets. The usual dosage is stated in the package insert for complete prescribing. The medication contains Hydrochloride 7°F and should be kept under USP controlled temperature. The medication is manufactured by Tro Pharmaceutical Industries Ltd and distributed by Taro Pharmaceutics USA. Please note that the text is incomplete with broken lines and missing information.*
FDA Label Image

Principal Display Panel (5 mg Tablet Bottle Label)

Principal Display Panel (5 mg Tablet Bottle Label)
This is a medication label for Fluphenazine tablets, a prescription drug used to treat certain mental and emotional conditions. The label lists the storage requirements and usage instructions for the tablets, including protecting the medication from light and excessive heat. The manufacturer is Taro Pharmaceuticals and the tablets contain Hydrochloride.*
FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Principal Display Panel (10 mg Tablet Bottle Label)
NDC 51672-4236-1 is a prescription medication containing 100 tablets of Fluphenazine Hydrochloride USP. The usual dosage can be found in the package insert which also contains complete prescribing information. The tablets should be dispensed in a tight container with a child-resistant closure as defined by the USP. The medication should be protected from excessive heat and light, and stored at 21° to 25°C (68° to 77°F) according to USP Controlled Room Temperature guidelines. This medication is intended for adult use only and should be kept out of reach of children. Manufactured by Taro Pharmaceuticals Industries Ltd, Halfa Bay, Israel, and distributed by Taro Pharmaceuticals U., Hawthorne, NY 10532.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.